Microfluidics is the study of systems that can process small quantities of fluids by using tiny channels having dimensions at the microscale – typically tens to hundreds of micrometres. Although in the nascent stage, microfluidics is rapidly emerging as a breakthrough technology that finds applications in diverse fields ranging from biology and chemistry to information technology and optics.
The global Microfluidics market is expected to grow at a sound pace in the times to follow. Several factors that are significantly contributing towards the growth of the market include high incidence of chronic diseases, easy to carry and use device, increasing need for point of care testing and a faster timeline for analysis completion. Besides, rising old age population will help the global microfluidics market to grow at higher level in the forecast period.
On the down side, there are certain challenges in incorporating microfluidics technology into existing workflows. This, coupled with the presence of complex and time-consuming regulatory standards, are the key factors hampering the growth of the microfluidics market. Apart from this, the emergence of microfluidics-based 3D cell culture systems, such as organ-on-a-chip and increasing applications of drug delivery technologies, creates notable growth opportunities for players operating in the market.
Covid-19 Impact on Microfluidics Market
In addition, the current Microfluidics Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Microfluidics Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
Microfluidics Market Segment Overview
Based on application, the In vitro Diagnostics segment is projected to grow at the highest rate during the forecast period. This is due to rising demand for pregnancy kits and associated devices and instruments. Furthermore, other important aspects such as the high adoption of microfluidic techniques in laboratory analytical testing and point-of-care testing, rising demand for point-of-care testing, increasing need for miniaturized and portable diagnostic equipment, and the growing incidence of chronic diseases are escalating the growth of this segment.
Microfluidics Market, By Product
· Instruments
· Microfluidic Chips
· Cartridges & Reagents
Microfluidics Market, By Application
· Peripheral Vascular Diseases
· Wound Care Management
· Pharmaceutical & Biotech Research
· In vitro Diagnostics
· Drug Delivery
Microfluidics Market, By Material
· Polymer Based
· Glass Based
Microfluidics Market, By End User
· Hospital
· Academic & Research Institutes
· Diagnostic Lab
· Homecare Settings
Microfluidics Market Regional Overview
In terms of region, North America holds a dominant position in the global Microfluidics market. The growth of this region can be mainly attributed to various factors such as a well-established health care sector, a robust framework for reimbursement, and increasing old age population in this region. Further, some credit in making North America a dominant region in the microfluidics market in the forecast period also goes to higher adoption of new therapeutics. Additionally, it is also worth noting here that in the United States of America, focus on Research and Development is sharp and point of care diagnostics and molecular diagnostics are extensive. And, this fact well for the region in the years ahead. Then again, the market in Asia Pacific is expected to witness a significant growth rate over the forecast period. The ever-increasing need for healthcare services, which increased the demand for medical diagnostics in this region certainly rises the growth of the market. China is a prominent country for Microfluidics market in the Asia Pacific.
Microfluidics Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Microfluidics Market, Key Players
· Danaher Corporation
· PerkinElmer Inc.
· Agilent Technologies Inc.
· Bio-Rad Laboratories Inc.
· Thermo Fisher Scientific Inc.
· Illumina, Inc.
· F. Hoffmann-La Roche Ltd
· Life Technologies Corporation
· Abbott Laboratories
· Qiagen
· Biomérieux
· Elveflow
· Cellix Ltd.
· Micronit Micro Technologies B.V.
· Fluidigm Corporation
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Microfluidics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Product
- 5.2.1. Instruments
- 5.2.2. Microfluidic Chips
- 5.2.3. Cartridges & Reagents
- 5.3. Market Analysis, Insights and Forecast – By Application
- 5.3.1. Peripheral Vascular Diseases
- 5.3.2. Wound Care Management
- 5.3.3. Pharmaceutical & Biotech Research
- 5.3.4. In vitro Diagnostics
- 5.3.5. Drug Delivery
- 5.4. Market Analysis, Insights and Forecast – By Material
- 5.4.1. Polymer Based
- 5.4.2. Glass Based
- 5.5. Market Analysis, Insights and Forecast – By End User
- 5.5.1. Hospital
- 5.5.2. Academic & Research Institutes
- 5.5.3. Diagnostic Lab
- 5.5.4. Homecare Settings
- 5.6. Market Analysis, Insights and Forecast – By Region
- 5.6.1. North America
- 5.6.2. Europe
- 5.6.3. Asia Pacific
- 5.6.4. Latin America, Middle East and Africa
6. North America Microfluidics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Product
- 6.2.1. Instruments
- 6.2.2. Microfluidic Chips
- 6.2.3. Cartridges & Reagents
- 6.3. Market Analysis, Insights and Forecast – By Application
- 6.3.1. Peripheral Vascular Diseases
- 6.3.2. Wound Care Management
- 6.3.3. Pharmaceutical & Biotech Research
- 6.3.4. In vitro Diagnostics
- 6.3.5. Drug Delivery
- 6.4. Market Analysis, Insights and Forecast – By Material
- 6.4.1. Polymer Based
- 6.4.2. Glass Based
- 6.5. Market Analysis, Insights and Forecast – By End User
- 6.5.1. Hospital
- 6.5.2. Academic & Research Institutes
- 6.5.3. Diagnostic Lab
- 6.5.4. Homecare Settings
- 6.6. Market Analysis, Insights and Forecast – By Country
- 6.6.1. U.S.
- 6.6.2. Canada
7. Europe Microfluidics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Product
- 7.2.1. Instruments
- 7.2.2. Microfluidic Chips
- 7.2.3. Cartridges & Reagents
- 7.3. Market Analysis, Insights and Forecast – By Application
- 7.3.1. Peripheral Vascular Diseases
- 7.3.2. Wound Care Management
- 7.3.3. Pharmaceutical & Biotech Research
- 7.3.4. In vitro Diagnostics
- 7.3.5. Drug Delivery
- 7.4. Market Analysis, Insights and Forecast – By Material
- 7.4.1. Polymer Based
- 7.4.2. Glass Based
- 7.5. Market Analysis, Insights and Forecast – By End User
- 7.5.1. Hospital
- 7.5.2. Academic & Research Institutes
- 7.5.3. Diagnostic Lab
- 7.5.4. Homecare Settings
- 7.6. Market Analysis, Insights and Forecast – By Country
- 7.6.1. UK
- 7.6.2. Germany
- 7.6.3. France
- 7.6.4. Italy
- 7.6.5. Spain
- 7.6.6. Russia
- 7.6.7. Rest of Europe
8. Asia Pacific Microfluidics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Product
- 8.2.1. Instruments
- 8.2.2. Microfluidic Chips
- 8.2.3. Cartridges & Reagents
- 8.3. Market Analysis, Insights and Forecast – By Application
- 8.3.1. Peripheral Vascular Diseases
- 8.3.2. Wound Care Management
- 8.3.3. Pharmaceutical & Biotech Research
- 8.3.4. In vitro Diagnostics
- 8.3.5. Drug Delivery
- 8.4. Market Analysis, Insights and Forecast – By Material
- 8.4.1. Polymer Based
- 8.4.2. Glass Based
- 8.5. Market Analysis, Insights and Forecast – By End User
- 8.5.1. Hospital
- 8.5.2. Academic & Research Institutes
- 8.5.3. Diagnostic Lab
- 8.5.4. Homecare Settings
- 8.6. Market Analysis, Insights and Forecast – By Country
- 8.6.1. China
- 8.6.2. India
- 8.6.3. Japan
- 8.6.4. Australia
- 8.6.5. South East Asia
- 8.6.6. Rest of Asia Pacific
9. Latin America, Middle East and Africa Microfluidics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Product
- 9.2.1. Instruments
- 9.2.2. Microfluidic Chips
- 9.2.3. Cartridges & Reagents
- 9.3. Market Analysis, Insights and Forecast – By Application
- 9.3.1. Peripheral Vascular Diseases
- 9.3.2. Wound Care Management
- 9.3.3. Pharmaceutical & Biotech Research
- 9.3.4. In vitro Diagnostics
- 9.3.5. Drug Delivery
- 9.4. Market Analysis, Insights and Forecast – By Material
- 9.4.1. Polymer Based
- 9.4.2. Glass Based
- 9.5. Market Analysis, Insights and Forecast – By End User
- 9.5.1. Hospital
- 9.5.2. Academic & Research Institutes
- 9.5.3. Diagnostic Lab
- 9.5.4. Homecare Settings
- 9.6. Market Analysis, Insights and Forecast – By Country
- 9.6.1. Brazil
- 9.6.2. Saudi Arabia
- 9.6.3. UAE
- 9.6.4. Rest of LAMEA
10. Competitive Analysis
- 10.1. Company Market Share Analysis, 2018
- 10.2. Key Industry Developments
- 10.3. Company Profile
- 10.4. Danaher Corporation
- 10.4.1. Business Overview
- 10.4.2. Segment 1 & Service Offering
- 10.4.3. Overall Revenue
- 10.4.4. Geographic Presence
- 10.4.5. Recent Development
- 10.5. PerkinElmer Inc.
- 10.6. Agilent Technologies Inc.
- 10.7. Bio-Rad Laboratories Inc.
- 10.8. Thermo Fisher Scientific Inc.
- 10.9. Illumina, Inc.
- 10.10. F. Hoffmann-La Roche Ltd
- 10.11. Life Technologies Corporation
- 10.12. Abbott Laboratories
- 10.13. Qiagen
- 10.14. Biomérieux
- 10.15. Elveflow
- 10.16. Cellix Ltd.
- 10.17. Micronit Micro Technologies B.V.
- 10.18. Fluidigm Corporation
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
